GlassScriptPhysician profile
Anthony L Valenti
NPI 1235201963
$454.23
in general payments reported to CMS, 2019-2025
12 companies · $22.28 in 2025
The $22.28 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $17.86 · 2022: $94.30 · 2023: $29.84 · 2024: $175 · 2025: $22.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $114.54 | 2019 | |
| Smith+Nephew, INC. | $61.90 | 2024-2025 | Regranex, Collagenase Santyl, Bone Anchors With Arthroscopic Delivery System |
| Bioventus LLC | $56.55 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Biocomposites INC | $56.30 | 2024 | |
| Acumed LLC | $33.55 | 2022 | |
| Biopro, INC. | $31.19 | 2024 | Hemi Toe |
| Osteomed LLC | $27.87 | 2022 | |
| Kerecis Limited | $18.68 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Misonix INC | $17.86 | 2020 | |
| Stryker Corporation | $14.26 | 2023 | Ortholoc 3di |
| Organogenesis INC. | $14.09 | 2022 | |
| Orthofix Medical, INC. | $7.44 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Valenti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.